Sanofi Noncurrent Financial Assets At Fair Value Through Profit Or Loss
Sanofi (SNY) had Noncurrent Financial Assets At Fair Value Through Profit Or Loss of EUR 1.00 billion as of 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss · last filed 2026-02-17
- 2025-12-31: Noncurrent Financial Assets At Fair Value Through Profit Or Loss 1.00B EUR.
- 2024-12-31: Noncurrent Financial Assets At Fair Value Through Profit Or Loss 1.03B EUR.
- 2023-12-31: Noncurrent Financial Assets At Fair Value Through Profit Or Loss 808.00M EUR.
- 2022-12-31: Noncurrent Financial Assets At Fair Value Through Profit Or Loss 823.00M EUR.
| Period end | Noncurrent Financial Assets At Fair Value Through Profit Or Loss |
|---|---|
| 2025-12-31 | 1.00B EUR 20-F · filed 2026-02-17 |
| 2024-12-31 | 1.03B EUR 20-F · filed 2026-02-17 |
| 2023-12-31 | 808.00M EUR 20-F · filed 2026-02-17 |
| 2022-12-31 | 823.00M EUR 20-F · filed 2025-02-13 |
| 2021-12-31 | 902.00M EUR 20-F · filed 2024-02-23 |
| 2020-12-31 | 890.00M EUR 20-F · filed 2023-02-24 |
| 2019-12-31 | 892.00M EUR 20-F · filed 2022-02-23 |